Press Room
Identifying patients most likely to benefit from initial nephrectomy
08/03/2012
C-reactive protein (CRP) is considered a useful serum marker for patients with RCC. However, its clinical utility in advanced metastatic renal cell carcinoma (AM-RCC), particularly in deciding whether to perform nephrectomy at the onset, is not well studied.
Third-line sunitinib following sequential use of cytokine therapy
08/03/2012
The aim of this study was to evaluate the use of sunitinib as third-line therapy for metastatic renal cell carcinoma (mRCC).
Hypoxia-Induced Alternative Splicing in Endothelial Cells
08/03/2012
Adaptation to low oxygen by changing gene expression is vitally important for cell survival and tissue development. The sprouting of new blood vessels, initiated from endothelial cells, restores the oxygen supply of ischemic tissues.
Depression Could Shorten Cancer Survival
08/02/2012
The link may be attributed to abnormal stress hormone regulation and inflammatory gene expression, researchers from the University of Texas M.D. Anderson Cancer Center reported in the Aug. 1 edition of PLoS ONE.
Registry compiles cancer data
08/01/2012
Every cancer patient who is diagnosed at CAMC or receives treatment at its hospitals is entered into a computer database.
Doctors Striving to Limit Radiation Doses
08/01/2012
Isabel Doran is only 4 years old, but she's already had about 15 CT scans â and every one comes with a dose of radiation.
Kidney Cancer Association in Top 5% of Charities
07/31/2012
International kidney cancer charity earns fifth consecutive Charity Navigator 4-star rating
July Kidney Cancer Association Newsletter
07/31/2012
Check out Gorjana and Griffin's custom necklace -- 50% of proceeds go to KCA!
Link between Kidney Removal and Erectile Dysfunction
07/31/2012
esearchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction.
CD133 predicts death in renal cell carcinoma
07/31/2012
To evaluate the prognostic impact of the histological expression of CD133 in renal cell carcinoma (RCC).
News Feed| Powered by NeonCRM |